3 active not recruiting, 2 completed, 2 recruiting. 5 Phase 1, 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 5 | Active not recruiting 2, Completed 2, Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow CarThera: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis. SonoCloud-4 (SC4) device - Amyotrophic Lateral Sclerosis, Charcot Disease | Phase 1 / Phase 2 | Recruiting | Assistance Publique - Hôpitaux de Paris | 23 | 2026-07-15 | 2026-08-10 |
| Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM SonoCloud-9 (SC9), Carboplatin, Lomustine - Glioblastoma, Recurrent Glioblastoma | Phase 3 | Active not recruiting | CarThera | 560 | 2024-01-29 | 2026-11-05 |
| Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma Balstilimab, Botensilimab, Liposomal Doxorubicin - Newly Diagnosed Glioblastoma, Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype | Phase 2 | Active not recruiting | Northwestern University | 25 | 2024-01-19 | 2026-09-29 |
| Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients SonoCloud® (9 transducers) - Malignant Brain Tumor, Malignant Glioma | Phase 1 | Recruiting | Assistance Publique - Hôpitaux de Paris | 24 | 2023-02-06 | 2026-05-06 |
| Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma Sonication for opening of blood-brain barrier, Chemotherapy, albumin-bound paclitaxel, Chemotherapy, carboplatin - Glioblastoma, Gliosarcoma | Phase 1 / Phase 2 | Active not recruiting | Northwestern University | 57 | 2020-10-29 | 2026-10-26 |
| Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9 SonoCloud-9, Carboplatin - Glioblastoma, Adult | Phase 1 / Phase 2 | Completed | CarThera | 38 | 2019-02-18 | 2022-09-07 |
| Blood Brain Barrier Opening in Alzheimer' Disease SONOCLOUD® - Alzheimer Disease | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 10 | 2017-06-26 | 2022-04-12 |
Glioblastoma (4) · Gliosarcoma (2) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Brain Neoplasms (1) · Frontotemporal Dementia (1) · Glioma (1) · Neoplasms, Germ Cell and Embryonal (1) · Neuroinflammatory Diseases (1) · Plaque, Amyloid (1)
Carboplatin (3) · Albumin-Bound Paclitaxel (1) · Drug Therapy (1) · Lomustine (1) · Sonication (1) · Temozolomide (1) · balstilimab (1) · liposomal doxorubicin (1)
France (5) · United States (4) · Austria (1) · Belgium (1) · Denmark (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1) · Switzerland (1)
Roger Stupp, MD (2) · Adam M Sonabend, MD (1) · Adam Sonabend, MD (1)
PMID 37142373, PMID 34815790, PMID 35260178, PMID 35552677, PMID 38396134, PMID 39028616, PMID 39724015
2016 (1), 2023 (1)